Safety and Pharmacokinetics of Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) in Participants With Alpha1-Antitrypsin Deficiency
Clinical trial NCT02870309 · COMPLETED
Trial details
- NCT number
- NCT02870309
- Sponsor
- Grifols Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-29
- Primary completion
- 2017-03-15
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.